Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F6QX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,513
Award facts
- Contract value 100% obligated
- $13,512.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) valued at $13,512.62. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. Performance is based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for November 19, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company holds extensive federal contract awards predominantly with the Defense Logistics Agency, supplying a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for ondansetron—an antiemetic medication commonly used in medical settings—represents a routine transactional order under the larger IDC vehicle, demonstrating the company's ongoing capability to fulfill the Defense Health Agency's pharmaceutical supply requirements through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F6QX7?
SPE2DR26F6QX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F6QX7 worth?
The government has obligated $13,513 on SPE2DR26F6QX7.
Is contract SPE2DR26F6QX7 an order under another contract?
Yes. SPE2DR26F6QX7 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6QX7 competed?
The extent of competition for SPE2DR26F6QX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award